Chance variability makes it impossible to assess reliably whether individual trusts are meeting annual targets for reduction in the risk of MRSA infection
No takes yet. Share an insight, caveat, or question.
David J. Spiegelhalter (2005) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: